RapidDx

RapidDx (formerly known as Baseline Bioscience and Baseline Global) is a biotechnology company. It develops the Rapid Assessment Device (RAD), a non-invasive, disposable solution for the initial assessment of brain-related and other conditions, such as traumatic brain injury, concussions, Post-Traumatic Stress Disorder, and COVID-19.